Sign In
Buy AERI
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Gone: Triangle public companies lose $30 billion in value during 1Q 2020
06:54pm, Thursday, 02'nd Apr 2020
Most Triangle public companies have seen their market valuations fall in 1Q2020.
So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature
10:51am, Wednesday, 01'st Apr 2020
Success in clinical trials doesn't guarantee success on the market.
First Republic Investment Management Inc. Raises Position in Aerie Pharmaceuticals Inc (NASDAQ:AERI)
10:04am, Wednesday, 01'st Apr 2020
First Republic Investment Management Inc. grew its position in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 63.9% during the 4th quarter, according to the company in its most recent disclosure with the
Stifel Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $40
12:00am, Wednesday, 01'st Apr 2020Aerie Pharmaceuticals participates in a conference call with Stifel AERI
01:24pm, Tuesday, 31'st Mar 2020
Aerie Pharmaceuticals participates in a conference call with Stifel AERI
3,208 Shares in Aerie Pharmaceuticals Inc (NASDAQ:AERI) Purchased by Great West Life Assurance Co. Can
11:50am, Monday, 30'th Mar 2020
Great West Life Assurance Co. Can acquired a new stake in Aerie Pharmaceuticals Inc (NASDAQ:AERI) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 3,208 shares of the company’s
Belpointe Asset Management LLC Makes New $156,000 Investment in Aerie Pharmaceuticals Inc (NASDAQ:AERI)
11:13am, Monday, 30'th Mar 2020
Belpointe Asset Management LLC bought a new position in shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) during the 4th quarter, according to the company in its most recent 13F filing with the Securi
Aerie Pharmaceuticals Inc (NASDAQ:AERI) Short Interest Update
07:04am, Monday, 30'th Mar 2020
Aerie Pharmaceuticals Inc (NASDAQ:AERI) was the target of a large decrease in short interest during the month of March. As of March 13th, there was short interest totalling 11,576,000 shares, a decrea
Aerie Pharmaceuticals (NASDAQ:AERI) Rating Reiterated by Needham & Company LLC
10:10am, Sunday, 29'th Mar 2020
Aerie Pharmaceuticals (NASDAQ:AERI)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a research report issued on Friday, AnalystRatings.com reports. They presently have a $40.
Reviewing Agenus (NASDAQ:AGEN) & Aerie Pharmaceuticals (NASDAQ:AERI)
06:06am, Saturday, 28'th Mar 2020
Agenus (NASDAQ:AGEN) and Aerie Pharmaceuticals (NASDAQ:AERI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their
Needham Sticks to Their Buy Rating for Aerie Pharma (AERI)
11:27am, Friday, 27'th Mar 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $40.00. The company's shares closed last
Needham Sticks to Their Buy Rating for Aerie Pharma (AERI)
11:27am, Friday, 27'th Mar 2020
Needham analyst
Serge Belanger
maintained a
Buy
rating on Aerie Pharma (
AERI
–
Research Report
) today and set a price target of
$40.00
. The company’s shares closed last Monday at $13.50, close
Aerie Pharma (AERI) Received its Third Buy in a Row
11:27am, Friday, 27'th Mar 2020
After Needham and Oppenheimer gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy, this time from Mizuho
Aerie Pharma (AERI) Received its Third Buy in a Row
11:27am, Friday, 27'th Mar 2020
After Needham and Oppenheimer gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy, this
Healthcare Pro James Flynn Picks up These 3 Stocks on the Cheap
02:18pm, Wednesday, 25'th Mar 2020
And just like that, stocks have landed back in the green. Following a several week long market performance that can only be described as tumultuous, the market notched its best single-day advance in a
